TuisRKDA • NASDAQ
add
Arcadia Biosciences Inc
Vorige sluiting
$3,48
Dagwisseling
$3,35 - $3,51
Jaarwisseling
$1,87 - $10,31
Markkapitalisasie
4,64 m USD
Gemiddelde volume
5,72 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,54 m | 18,41% |
Bedryfskoste | 2,24 m | 20,32% |
Netto inkomste | -1,61 m | 37,20% |
Netto winsgrens | -104,88 | 46,97% |
Wins per aandeel | -0,87 | — |
EBITDA | -1,75 m | -34,02% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 6,58 m | -58,11% |
Totale bates | 15,24 m | -35,05% |
Totale aanspreeklikheid | 5,09 m | -36,89% |
Totale ekwiteit | 10,15 m | — |
Uitstaande aandele | 1,36 m | — |
Prys om te bespreek | 0,46 | — |
Opbrengs op bates | -26,99% | — |
Opbrengs op kapitaal | -38,88% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -1,61 m | 37,20% |
Kontant van bedrywe | -1,75 m | 39,27% |
Kontant van beleggings | 180,00 k | 3 500,00% |
Kontant van finansiering | 4,00 k | -42,86% |
Netto kontantverandering | -1,57 m | 45,42% |
Beskikbare kontantvloei | 3,25 m | 6 857,40% |
Meer oor
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
Gestig
2002
Hoofkwartier
Webwerf
Werknemers
21
